NCT07351305

Brief Summary

The investigators want to test a treatment for posttraumatic stress disorder (PTSD) especially designed for military veterans and service members with mild or moderate traumatic brain injuries (TBI) and PTSD. The treatment will include individual psychotherapy sessions to manage PTSD.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
15mo left

Started Mar 2026

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress12%
Mar 2026Aug 2027

First Submitted

Initial submission to the registry

January 9, 2026

Completed
11 days until next milestone

First Posted

Study publicly available on registry

January 20, 2026

Completed
1 month until next milestone

Study Start

First participant enrolled

March 5, 2026

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2027

Expected
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2027

Last Updated

March 9, 2026

Status Verified

January 1, 2026

Enrollment Period

12 months

First QC Date

January 9, 2026

Last Update Submit

March 5, 2026

Conditions

Keywords

Non-trauma interventionVeteransService Members

Outcome Measures

Primary Outcomes (1)

  • PTSD Checklist-DSM-5 (PCL-5)

    The PCL-5 is a 20-item self-report measure designed to assess PTSD symptoms as defined by the DSM-5. The scoring involves summing the responses to 20 items (0 to 80) with higher scores indicating more severe PTSD.

    Baseline to 6 months post treatment (approximately 8 months)

Secondary Outcomes (10)

  • Credibility and Expectancy Questionnaire

    Baseline to 2 weeks post treatment (approximately 10 weeks)

  • Clinician Administered PTSD Scale for the Diagnostic and Statistical Manual of Mental Disorders Version 5 (DSM-5)

    Baseline to 6 months post treatment (approximately 8 months)

  • Generalized Anxiety Disorder-7 (GAD-7)

    Baseline to 6 months post treatment (approximately 8 months)

  • Patient Global Impressions (PGI) Scale

    2 weeks post treatment to 6 months post treatment

  • Alcohol Use Disorders Identification Test (AUDIT)

    Baseline to 6 months post treatment (approximately 8 months)

  • +5 more secondary outcomes

Study Arms (1)

Active duty service members and veterans seeking clinical care for TBI

EXPERIMENTAL

Male and female active duty service members and veterans at least 18 years of age who are seeking clinical care for mild or moderate Traumatic Brain Injury (TBI) symptoms at the Intrepid Spirit Center located on Fort Hood who also have a co-occurring diagnosis of PTSD

Behavioral: Non-Trauma Treatment for TBI and PTSD

Interventions

The treatment includes 8 sessions with each session lasting approximately 60 minutes. Sessions will cover relaxation training, identifying stress, stress management, and problem solving.

Also known as: T3 PTSD
Active duty service members and veterans seeking clinical care for TBI

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Ability of participant to understand and the willingness to sign a written informed consent document based on interviewer assessment and clinical judgement.
  • Any veteran or active duty service member (age 18 or above) diagnosed with mild or moderate TBI as determined by the Ohio State University Brain Injury Identification Method
  • Participant meets diagnostic criteria for PTSD based on Clinician-Administered PTSD Scale (CAPS-5) interview as described by the National Center for PTSD which includes at least one Criterion B symptom, one Criterion C symptom, two Criterion D symptoms, and two Criterion E symptoms as well as meeting Criterions F and G.
  • Ability to read, write, and speak English based on interviewer assessment and clinical judgement.

You may not qualify if:

  • Participant is actively engaged in a behavioral intervention primarily targeting PTSD.
  • Participant has a psychiatric problem that warrants immediate treatment as indicated in the electronic health record, flagged during testing, or confirmed by a clinician through screening or review of clinical notes.
  • Participant demonstrates significant cognitive impairment that could impact treatment adherence/benefit based on interviewer assessment and clinical judgement.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Carl R Darnall Army Medical Center

Fort Hood, Texas, 76544, United States

RECRUITING

MeSH Terms

Conditions

Stress Disorders, Post-TraumaticBrain Injuries, Traumatic

Interventions

Whole-Body Irradiation

Condition Hierarchy (Ancestors)

Stress Disorders, TraumaticTrauma and Stressor Related DisordersMental DisordersBrain InjuriesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesCraniocerebral TraumaTrauma, Nervous SystemWounds and Injuries

Intervention Hierarchy (Ancestors)

RadiotherapyTherapeuticsInvestigative Techniques

Study Officials

  • Cindy McGeary, PhD

    The University of Texas Health Science Center at San Antonio

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Cindy McGeary, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: This study is a single group pilot test
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

January 9, 2026

First Posted

January 20, 2026

Study Start

March 5, 2026

Primary Completion (Estimated)

March 1, 2027

Study Completion (Estimated)

August 1, 2027

Last Updated

March 9, 2026

Record last verified: 2026-01

Data Sharing

IPD Sharing
Will share

Individual Participant data may be shared with the research study team, the IRB, the Department of Defense representatives and state or Federal Government officials where required by law. Only deidentified data will be shared in a peer reviewed journal or in the summary results in ClinicalTrials.gov.

Shared Documents
STUDY PROTOCOL, SAP, ICF
Time Frame
Public data will be shared at the end of the study after the data is analyzed.

Locations